Patriot Financial Group Insurance Agency’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	2269
2021 Q2	$0	Buy	+1	New	+$113	﹤0.01%	2181
2021 Q1	–	Sell	-1	Closed	–	–	2101
2020 Q4	$0	Buy	+1	New	+$131	﹤0.01%	2034

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Patriot Financial Group Insurance Agency's RETA Position: Q3 2021 in Review

Patriot Financial Group Insurance Agency sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2021, closing a stake of 1 share.

Patriot Financial Group Insurance Agency first reported a position in RETA in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

Patriot Financial Group Insurance Agency reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 1 Reata Pharmaceuticals, Inc. Class A Common Stock share in Q3 2021.
Patriot Financial Group Insurance Agency first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2020 and held it in 2 quarters.
Patriot Financial Group Insurance Agency's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $0 in Q2 2021.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2021, filed 24 Nov 2021.